Itafos Stock Forecast, Price & News

+0.04 (+3.08 %)
(As of 07/26/2021 02:26 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume3,279 shs
Average Volume15,722 shs
Market CapitalizationC$250.22 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive IFOS News and Ratings via Email

Sign-up to receive the latest news and ratings for Itafos and its competitors with MarketBeat's FREE daily newsletter.

About Itafos

Itafos operates as a phosphate and specialty fertilizer platform company. It operates through Conda, Arraias, and Development and Exploration segments. The company produces and sells monoammonium phosphate (MAP), MAP with micronutrients, superphosphoric acid, merchant grade phosphoric acid, single superphosphate (SSP), SSP with micronutrients, and ammonium polyphosphate. It also owns 100% interests in the Farim, a phosphate mine project situated in Farim, Guinea-Bissau; Araxá, a rare earth element and niobium mine and extraction plant project that covers an area of approximately 226 hectares situated in Minas Gerais, Brazil; Paris Hills, a phosphate mine project, which covers an area of approximately 1,010 hectares located in Idaho, the United States; and Mantaro, a phosphate mine project that covers an area of approximately 12,800 hectares located in Junin, Peru, as well as 99.4% interest in the Santana, an integrated phosphate mine and fertilizer plant project, which covers an area of approximately 233,070 hectares located in Pará, Brazil. The company was formerly known as MBAC Fertilizer Corp. and changed its name to Itafos in December 2016. Itafos is based in George Town, the Cayman Islands. Itafos is a subsidiary of CL Fertilizers Holding LLC.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.22 out of 5 stars

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Itafos (CVE:IFOS) Frequently Asked Questions

Is Itafos a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Itafos in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Itafos stock.
View analyst ratings for Itafos
or view top-rated stocks.

What stocks does MarketBeat like better than Itafos?

Wall Street analysts have given Itafos a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Itafos wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Itafos' stock price been impacted by Coronavirus (COVID-19)?

Itafos' stock was trading at C$0.38 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, IFOS stock has increased by 252.6% and is now trading at C$1.34.
View which stocks have been most impacted by COVID-19

What price target have analysts set for IFOS?

1 equities research analysts have issued 12 month price objectives for Itafos' shares. Their forecasts range from C$2.00 to C$2.00. On average, they anticipate Itafos' stock price to reach C$2.00 in the next twelve months. This suggests a possible upside of 49.3% from the stock's current price.
View analysts' price targets for Itafos
or view top-rated stocks among Wall Street analysts.

Who are Itafos' key executives?

Itafos' management team includes the following people:
  • Mr. George David Delaney, CEO & Director (Age 60, Pay $626.93k)
  • Mr. George Wrigley Burdette, Chief Financial Officer
  • Mr. Timothy Anthohy Vedder III, VP Operations & GM of Itafos Conda
  • Mr. Fernando Planchart Padula, Gen. Counsel & Corp. Sec.
  • Mr. David Brush, Chief Strategy Officer (Age 56)

Who are some of Itafos' key competitors?

What other stocks do shareholders of Itafos own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Itafos investors own include Nutrien (NTR) and 27557 (MBC.TO) (MBC).

What is Itafos' stock symbol?

Itafos trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IFOS."

How do I buy shares of Itafos?

Shares of IFOS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Itafos' stock price today?

One share of IFOS stock can currently be purchased for approximately C$1.34.

How much money does Itafos make?

Itafos has a market capitalization of C$250.22 million and generates C$274.97 million in revenue each year.

How many employees does Itafos have?

Itafos employs 308 workers across the globe.

What is Itafos' official website?

The official website for Itafos is

Where are Itafos' headquarters?

Itafos is headquartered at Ugland House, GRAND CAYMAN, ON KY1-1104, Cayman Islands.

This page was last updated on 7/27/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.